OBJECTIVE: To test the hypothesis that the triad of hyperandrogenism, insulin resistance and acanthosis nigricans (HAIR-AN syndrome) in the presence of obesity, also known as type C insulin resistance (type C), is caused by mutations at the tyrosine kinase domain of the insulin receptor gene. DESIGN: A candidate gene approach to study the molecular basis for a syndrome of obesity. SUBJECTS: 15 patients with type C insulin resistance and 25 control individuals. MEASUREMENTS: Analysis of polymerase chain reaction (PCR) products of exons 17 to 21 of the insulin receptor gene, comprising the tyrosine kinase domain, for single strand conformational polymorphisms (SSCP) and sequence analysis of exons with variant SSCP patterns. RESULTS: A synonymous C to T substitution in position 3 of codon 984, which does not alter the amino acid predicted, was found in one patient and in four of 25 control individuals. CONCLUSION: Type C insulin resistance is not commonly caused by mutations in the tyrosine kinase domain of the insulin receptor gene.
Introduction
Insulin resistance is a central feature in several syndromes such as Leprechaunism, Rabson-Mendenhall syndrome and type A insulin resistance (type A). These are rare diseases, known to be caused by mutations in the insulin receptor gene. 1 Type C insulin resistance (type C), is a more common condition, which like type A, is de®ned by hyperandrogenism, insulin resistance, acanthosis nigricans (HAIR-AN syndrome) in the absence of autoimmune disease. Autoimmunity is typical of type B insulin resistance. Unlike type A, type C is characterized by the presence of obesity. Type C is found in 5% of patients with polycystic ovary syndrome (PCOS). 2 It appears that both PCOS and acanthosis nigricans are due to the growth promoting effects of excess insulin. 1 However, the etiology of type C is not known. Several studies support the notion that obesity alone does not explain the resistance to insulin found in type C: Using the insulin euglycaemic clamp, we have previously shown that patients with type C have more severe insulin resistance than obese individuals of comparable weight. 3 Others have shown that after patients with type C dieted to reach a normal weight, insulin binding to their monocytes improved, but did not normalize, suggesting an intrinsic defect in insulin binding. 4 Assuming that type C may be a mild form of classic' type A insulin resistance, we proposed the hypothesis that type C is caused by mutations at the insulin receptor gene. Supporting evidence was provided by two case reports: In a study of the insulin receptor gene in non insulin dependent diabetes mellitus (NIDDM), the only diabetic patient found to have a mutation in the insulin receptor gene was also obese, with hyperandrogenism, insulin resistance and acanthosis nigricans. 5 A mutation in the insulin receptor gene was reported in one other patient with HAIR-AN syndrome and obesity. 6 While our study was underway, three studies were published which examined the insulin receptor gene in patients with various phenotypes, including PCOS, 7, 8 type A, 8, 9 HAIR-AN syndrome, acanthosis nigricans, pseudoacromegaly, congenital generalized lipodystrophy, Alstro Èm's syndrome, Syndrome X and Rabson-Mendenhall syndrome. 8 In some of these patients, hyperandrogenism, insulin resistance and acanthosis nigricans were associated with obesity, suggesting type C insulin resistance. Mutations in the insulin receptor gene were not detected in any of the latter individuals.
Our study examines the tyrosine kinase domain of the insulin receptor gene in a large group of patients with type C. We chose the tyrosine kinase domain because, although this region comprises only 20% of the insulin receptor coding region, 50% of the known mutations in type A are found there. 1 
Subjects and methods

Subjects
Fifteen patients (12 women and 3 men) with type C insulin resistance were studied. Their clinical characteristics appear in Table 1 . The diagnosis was generalized to include men. We determined insulin resistance using the insulin euglycaemic clamp, in nine subjects 3 ; in four subjects, the diagnosis was based on a fasting insulin level of b180 pmolal; in two of the four diabetic patients, it was based on a therapeutic insulin requirement of over 100 Uad. All the patients were obese with a body mass index (BMI) (mean AE standard deviation (s.d.)) of 37.1 AE 4.1 kgam 2 and all had histologically proven acanthosis nigricans. Eight women were hirsute and eight had menstrual irregularities. The control group comprised 25 generally healthy individuals (9 women and 16 men) recruited at an Annual Check-Up Clinic. Exclusion criteria were: obesity, diabetes and a history of diabetes in a ®rst degree relative. The control individuals' BMI (mean AE s.d.) was 26.6 AE 2.7 kgam 2 . Fasting insulin levels were obtained in some of the control individuals.
Informed consent was obtained from all subjects.
DNA preparation
DNA was prepared from leukocytes in a blood sample drawn from each individual as previously described.
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PCR-SSCP
Exons 17 to 21 of the insulin receptor gene, comprising the tyrosine kinase domain were ampli®ed and analyzed using the polymerase chain reaction with the single strand conformational polymorphism (PCR-SSCP) method using a modi®cation 12 of the method described by Orita et al. 13 Exon 17, which was found to be relevant, was examined in the control individuals by the same method. Pairs of oligonucleotide primers were chosen from sites in the introns that ank each exon, as suggested by Seino et al. 14 The downstream primer of exon 17 was selected from a region of the exon just adjacent to the intron, in order to exclude a common polymorphic site. 5 Its sequence was 5 H -TAGTGGCAGGTGAAGCCCTTC-3 H . Exon 21 was analyzed using another pair of primers in addition to the pair mentioned above. The sequence of the upstream primer was 5
H -GCGCGCGTGTG-TGTGTGTGTC-3
H , and that of the downstream primer was 5 H -GCATGTAAAGACAAGCTATG-3 H . The oligonucleotide primers were synthesized by the phosphotriester method on a DNA synthesizer (model 394, Applied Biosystems, San Diego, CA) and puri®ed by the high performance liquid chromatography (HPLC) method. Samples were run on a polyacrylamide gel under two electrophoresis conditions: on a 10% glycerol gel at ambient temperature and on a gel without glycerol at 4±8 C. Normal and mutant controls were run on each gel. The mutant control DNA was from patient RM-1, a patient with Rabson-Mendenhall syndrome who has a C to T substitution in position 1 of codon 1000, exon 17 of the insulin receptor gene. 
Direct sequencing after asymmetric PCR
Exons with patterns that, on SSCP analysis, differed from normal, underwent sequence analysis after asymmetric PCR by a modi®ed method. 15 The same primers were used for asymmetric PCR and for PCR-SSCP. The single strand DNA PCR product was sequenced by the dideoxy chain termination method using T7 DNA polymerase (Sequenase version 2.0, USB, Cleveland, OH) according to the manufacturer's instructions, using deoxyadenosine 5
S]dATP) (1000 Ci/mmol) (Buckinghamshire International, Amersham, UK) for direct incorporation. The sequencing primer used was the limiting primer in the asymmetric PCR reaction. Both the sense and the anti-sense strands were sequenced. As with PCR-SSCP, exon 21 underwent complete analysis using the additional pair of primers as well.
Results
Variant SSCP patterns were detected in two patients with type C insulin resistance. Exon 17 from patient number 4 had an altered mobility under both gel electrophoresis conditions: with 10% glycerol at ambient temperature, as well as without glycerol at 4±8 C (see Figure 1 ). Direct sequencing of exon 17 from patient number 4 showed a heterozygous C to T substitution in position 3 of codon 984, which did not alter the predicted amino acid, tyrosine (see Figure 2 ). This was con®rmed by sequencing of the anti-sense strand. A SSCP pattern identical to that found in exon 17 from patient number 4, also appeared in four (two men and two women) of the 25 control individuals (see Figure 3) , and on sequencing they had the same heterozygous C to T substitution in position 3 of codon 984. Their BMI range was 24.5±26.6 kg/m 2 and their fasting insulin level range was 29±76 pmol/l. Exon 21 from patient number 7 only had a different SSCP pattern when run on a 10% glycerol gel at ambient temperature (see Figure 4) . However, on direct sequencing of the sense and anti-sense strands, despite a good quality sequence ladder, a base substitution was not detected. This particular exon was also analyzed using an additional pair of primers and in this case too, the variant SSCP pattern was demonstrated, but no substitution was detected by sequencing.
Discussion
Our analysis of the tyrosine kinase domain in 15 obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans, revealed variant SSCP patterns in two cases. On sequence analysis, a C to T substitution in position 3 of codon 984 was found in one patient. No change was found on sequence analysis of the second variant SSCP pattern.
The C to T substitution changes codon 984 from TAC to TAT, both of which encode tyrosine. This change had been previously found in ®ve other patients with various forms of insulin resistance 7, 9, 12 and not in the three normal individuals whose insulin receptor genes had been sequenced. 14, 16, 17 As codon 984 is conserved as TAC in insulin receptor genes from other species 18, 19 and in another tyrosine kinase receptor gene, 20 we initially speculated that the exon 17 substitution, which is located near the intron 16 / exon 17 junction, may not be a`silent' polymorphism, but instead might disrupt normal splicing by affecting the secondary structure of pre-mRNA, as occurs in certain diseases. 21, 22, 23 However, as we found the codon 984 C to T substitution in four of 25 nontype C individuals, this possibility is unlikely.
Our observation of a DNA fragment with variant mobility on SSCP analysis but no detectable abnormality on sequencing, is of interest. Since its introduction by Orita et al 13 in 1989, PCR-SSCP has been one of the most widely used methods to screen for mutations. This method's sensitivity in detecting mutations, is 70±100% for fragments of the size we studied and using, as we did, two electrophoresis conditions. 13,24±26 However, this technique's speci®-city has been tested rarely and only on a few specimens. 26 Our inability to detect a nucleotide change in the variant exon of our patient, led us to review the experience of other researchers. We found that false positives have been encountered, perhaps more fre- quently than has been reported 9, 27, 28 and this phenomenon is not well understood.
In conclusion, based on our study of 15 patients with type C insulin resistance and on the reported cases in the literature, it appears that this condition is not commonly caused by mutations in the tyrosine kinase domain of the insulin receptor gene. Studies are needed to examine further the insulin transduction cascade in patients with type C insulin resistance. 
